We are live on !
Find out more
Syquant Capital Portfolio holdings
AUM
$453M
Turnover
61.97%
1-Year Est. Return
6.35%
This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+6.35%
3 Year Est. Return
+159.76%
5 Year Est. Return
+344.81%
10 Year Est. Return
–
AUM
$138M
AUM Growth
+$94.5M
(+219%)
Cap. Flow
+$96.7M
Cap. Flow % of AUM
Cap. Flow %
70.26%
Top 10 Holdings %
Top 10 Hldgs %
99.95%
Holding
16
New
9
Increased
1
Reduced
–
Closed
5
Avg Time Held
Equity + Options
0.2
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.2
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics
HZNP
|
+$61.4M |
| 2 |
ISEE
IVERIC bio
ISEE
|
+$14.4M |
| 3 |
GLOP
GasLog Partners
GLOP
|
+$8.39M |
| 4 |
UNVR
Univar Solutions
UNVR
|
+$7.78M |
| 5 |
RADI
Radius Global Infrastructure
RADI
|
+$5.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MGI
MoneyGram International
MGI
|
+$4.67M |
| 2 |
AMYT
Amryt Pharma
AMYT
|
+$3.76M |
| 3 |
APEN
Apollo Endosurgery
APEN
|
+$2.98M |
| 4 |
Ferrari
RACE
|
+$273K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 75.38% |
| 2 | Industrials | 7.31% |
| 3 | Materials | 5.7% |
| 4 | Real Estate | 3.77% |
| 5 | Consumer Staples | 3.65% |
Similar funds
RS
Syquant Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Syquant Capital held 16 positions worth $138M, up 219% from $43.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Syquant Capital deployed $96.7M of net new capital in Q2 2023, opening 9 new positions and adding to 1 existing holding. Its largest new stake was IVERIC bio: 406,686 shares worth $16M.
By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 84% a quarter earlier, followed by Industrials and Materials.
On the sell side, the most notable exit was MoneyGram International, an estimated $4.67M sold.
- Syquant Capital's largest Q2 2023 buy was IVERIC bio: 406,686 shares worth $16M.
- Syquant Capital added most to Horizon Therapeutics in Q2 2023, an estimated $61.4M increase.
- Syquant Capital fully exited MoneyGram International in Q2 2023, selling an estimated $4.67M.
- Syquant Capital's ten largest holdings make up 100% of its $138M portfolio in Q2 2023.
- Syquant Capital opened 9 new positions and closed 5 in Q2 2023.
- Syquant Capital's portfolio value rose 219% quarter-over-quarter to $138M.
Based on Syquant Capital's 13F filing for Q2 2023, filed 10 Jul 2023.